mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

A recent study published in Genomic Psychiatry has unveiled a promising new therapy that may help improve memory and reduce ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

Capricor Therapeutics is taking a victory lap for their phase 2 Duchenne muscular dystrophy (DMD) trial. | Capricor ...

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The ...

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a ...

As of October 2024, there are more than thirty FDA-approved gene therapies, spanning a diverse array of diseases such as ...

Most investors unaware of the huge breakthroughs happening in biotech right now. But new technologies such as cancer-killing ...

Two years after the US agency placed the partial clinical hold, Avidity can resume the research of del-desiran as a treatment ...

In response to ongoing work across related industries regarding the use of mRNA vaccines, the U.S. Cattlemen’s Association has taken steps to include this new subject matter within its official Policy ...

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.